Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

NCT00526305 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00526305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00526305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Lead sponsor
PETHEMA Foundation
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2000
Completion date
April 30, 2005
Enrollment
100 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia